These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10712162)

  • 21. The enteric purinergic P2Y1 receptor.
    Wood JD
    Curr Opin Pharmacol; 2006 Dec; 6(6):564-70. PubMed ID: 16934527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates.
    Boyer JL; Delaney SM; Villanueva D; Harden TK
    Mol Pharmacol; 2000 Apr; 57(4):805-10. PubMed ID: 10727529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of potassium and calcium currents in neurones by molecularly-defined P2Y receptors.
    Brown DA; Filippov AK; Barnard EA
    J Auton Nerv Syst; 2000 Jul; 81(1-3):31-6. PubMed ID: 10869697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Purinergic regulation of microglia].
    Tozaki-Saitoh H; Tsuda M; Inoue K
    Nihon Yakurigaku Zasshi; 2010 Aug; 136(2):93-7. PubMed ID: 20702968
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective inhibition of beta(2)-adrenergic receptor-mediated cAMP generation by activation of the P2Y(2) receptor in mouse pineal gland tumor cells.
    Suh BC; Kim JS; Namgung U; Han S; Kim KT
    J Neurochem; 2001 Jun; 77(6):1475-85. PubMed ID: 11413231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2 receptors in the murine gastrointestinal tract.
    Giaroni C; Knight GE; Ruan HZ; Glass R; Bardini M; Lecchini S; Frigo G; Burnstock G
    Neuropharmacology; 2002 Dec; 43(8):1313-23. PubMed ID: 12527481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.
    Léon C; Hechler B; Freund M; Eckly A; Vial C; Ohlmann P; Dierich A; LeMeur M; Cazenave JP; Gachet C
    J Clin Invest; 1999 Dec; 104(12):1731-7. PubMed ID: 10606627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the P2 receptors.
    Boeynaems JM; Communi D; Gonzalez NS; Robaye B
    Semin Thromb Hemost; 2005 Apr; 31(2):139-49. PubMed ID: 15852217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P2 purinoceptor-mediated stimulation of adenylyl cyclase in PC12 cells.
    Yakushi Y; Watanabe A; Murayama T; Nomura Y
    Eur J Pharmacol; 1996 Oct; 314(1-2):243-8. PubMed ID: 8957242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging roles for P2X1 receptors in platelet activation.
    Mahaut-Smith MP; Tolhurst G; Evans RJ
    Platelets; 2004 May; 15(3):131-44. PubMed ID: 15203715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capacity for purinergic control of renin promoter via P2Y(11) receptor and cAMP pathways.
    van Der Weyden L; Adams DJ; Morris BJ
    Hypertension; 2000 Dec; 36(6):1093-8. PubMed ID: 11116131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.
    Léon C; Freund M; Ravanat C; Baurand A; Cazenave JP; Gachet C
    Circulation; 2001 Feb; 103(5):718-23. PubMed ID: 11156884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonists of the P2Y(AC)-receptor activate MAP kinase by a ras-independent pathway in rat C6 glioma.
    Grobben B; Claes P; Van Kolen K; Roymans D; Fransen P; Sys SU; Slegers H
    J Neurochem; 2001 Sep; 78(6):1325-38. PubMed ID: 11579141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P2Y2 nucleotide receptors inhibit trauma-induced death of astrocytic cells.
    Burgos M; Neary JT; González FA
    J Neurochem; 2007 Dec; 103(5):1785-800. PubMed ID: 17868308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purinergic P2 receptors modulate excitability but do not mediate pH sensitivity of RTN respiratory chemoreceptors.
    Mulkey DK; Mistry AM; Guyenet PG; Bayliss DA
    J Neurosci; 2006 Jul; 26(27):7230-3. PubMed ID: 16822980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
    Neary JT; McCarthy M; Kang Y; Zuniga S
    Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The platelet ATP and ADP receptors.
    Oury C; Toth-Zsamboki E; Vermylen J; Hoylaerts MF
    Curr Pharm Des; 2006; 12(7):859-75. PubMed ID: 16515502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
    Köles L; Furst S; Illes P
    Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P2Y receptors play a critical role in epithelial cell communication and migration.
    Klepeis VE; Weinger I; Kaczmarek E; Trinkaus-Randall V
    J Cell Biochem; 2004 Dec; 93(6):1115-33. PubMed ID: 15449317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonists and the purinergic nerve hypothesis: 2, 2'-pyridylisatogen tosylate (PIT), an allosteric modulator of P2Y receptors. A retrospective on a quarter century of progress.
    Spedding M; Menton K; Markham A; Weetman DF
    J Auton Nerv Syst; 2000 Jul; 81(1-3):225-7. PubMed ID: 10869725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.